Login / Signup

Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia.

Graça M DoresMartha S LinetRochelle E CurtisLindsay M Morton
Published in: Blood (2022)
Keyphrases
  • acute myeloid leukemia
  • allogeneic hematopoietic stem cell transplantation
  • human health
  • risk assessment
  • acute lymphoblastic leukemia
  • smoking cessation
  • replacement therapy